MISSILE INTERCEPTOR

Featured image by SOPA Images/SOPA Images/LightRocket via Getty Images

High-Grade Bonds

High-Grade Monthly: Record run stumbles on war footing as spreads rise

Projections for March volume were high after powerhouse totals in January and February, but spiraling events in the Middle East temporarily halted issuance.

Spiraling events in the Middle East have forced investment-grade debt issuers into safe harbors, throwing a record run for dealmaking through February off stride. That’s as corporate funding spreads over Treasuries — a propellant for IG through strong headwinds last year — indicate faltering risk sentiment, just as M&A and growth capital spending face critical tests of market demand.

March volume projections ranged from $180-250 billion, for an average estimate of $211 billion. That’s not unprecedented: The seasonally rife March period includes high totals of $261 billion in pandemic-era 2020, $192 billion in 2021 (against record-low funding costs at the time) and $231 billion in 2022 (as the Fed embarked on rate hikes).

Hard stop
Those estimates were gathered ahead of the start of hostilities in Iran, however. The primary engine shockingly sputtered out Monday and Tuesday (just one deal priced, a $1 billion offering for Japan-based Norinchukin Bank), and the silence was deafening. Comparable Monday-Tuesday totals to start prior early-March periods saw 19 deals clear last year, 23 in 2023 and 2024, and 25 in 2021.

Making up for those war-disrupted sessions, desks uncorked a 17-deal docket on Thursday totaling $31.3 billion, on top of Wednesday’s five-deal docket. The $50 billion priced this week through Thursday is still light relative to ambitious estimates.

Last week, respondents to Mischler Financial’s weekly syndicate survey called for as much as $85 billion to price for the first week of March, and the average estimate was more than $64 billion. For reference, large totals for comparable early-March weeks include roughly $73 billion last year, $48 billion in 2024, and $60 billion-plus in 2021 and 2022.

The little month that could
Sky-high March projections were informed by powerhouse totals in January and February, abetted by an expected early influx from hyperscalers and M&A candidates. But even those high hopes were tinged with anxiety, as spread levels for Morningstar’s IG and HY indices widened 12 bps and 33 bps in February, respectively.

In February, primary issuance reached $187 billion, nearly meeting ambitious Street forecasts. It marked the second-highest total for that month, which has run hot in recent years. February totals were $144-147 billion in 2023 and 2025, and a record $191 billion in February 2024. Pre-pandemic, the biggest February total was $109 billion, in 2015.

Deals for Oracle and Alphabet in February drove $45 billion of bonds to market to address open-ended AI spending needs. That is already nearly half the $93 billion placed across the IG hyperscaler cohort (Amazon, Microsoft, Meta, Oracle and Alphabet) in 2025, and it’s above all previous annual totals on record.

Against opaque outlooks for funding conditions, issuers of all stripes are taking big swings when they play the primary market. The average offering amount for the first two months of the year swelled to $2.07 billion, up roughly 20% from last year and 18% from 2024. It’s only ever been larger in 2016, when deals averaged $2.37 billion.

Size matters
Oracle — which started the AI bond-funding frenzy last September with an $18 billion offering — piled another $25 billion atop its bond stack on Feb. 2, the largest deal so far this year. In a move to placate nerves, Oracle shopped its bond offering alongside $5 billion of mandatory convertible preferred securities and also authorized a new at-the-market equity program of up to $20 billion.

While that equity component triggered a quick rally in Oracle bonds (its outstanding 5.95% long bonds gapped 25 bps tighter on Feb. 2), the relief was short-lived. Oracle’s new-issue 6.70% 2056 bonds (priced at T+180, versus T+125 for its comparable 5.95% 2055 issue priced last September) hit all-time highs in the T+230s this week.

Google parent Alphabet Inc. inked a $20 billion, seven-part transaction, along with a sterling-denominated offering, which included a rare 100-year bond. The firm will use proceeds to lock in liquidity as it plans to roughly double its capital spending this year.

That strong double-A print (versus triple-B for Oracle) included dollar-denominated 5.65% 30-year bonds priced at T+83. While less exposed to negative sentiment than Oracle, Alphabet’s notes nevertheless leaked wider to trade at T+86 on Monday.

AI funding needs expanded out from hyperscalers. Vertiv Holding Co., which designs, manufactures and services critical digital infrastructure for data centers, placed a $2.1 billion, four-part offering this month, its first investment-grade rated deal following recent rising-star upgrades.

M&A in play
After some false starts, M&A activity returned with gusto last month, surging to $33.95 billion, or 18% of the total. The market has not seen M&A volumes this strong since last March’s $51.5 billion (roughly 29% of the total). That month also featured jumbo deals from Mars Inc. ($26 billion to back its purchase of Kellanova), Synopsys ($10 billion to fund its Ansys buy) and Rio Tinto ($9 billion to fund its purchase of Arcadium).

Last month’s total is owed in part to Abbott Laboratories, which sold $20 billion in new bonds to back its $23 billion debt-funded purchase of Exact Sciences that is expected to close in the second quarter. Seven other issuers earmarked proceeds for M&A in February. Thermo Fisher Scientific placed a $3.8 billion, four-part offering as it raised funds to back its purchase of Clario Holdings, with an expected middle-of-the-year close. Cencora, the drug wholesale and distribution company, completed a $3 billion, five-part offering to fund its purchase of the remaining stake in OneOncology in a $4.6 billion transaction.

Market conditions last month were ideal to lure borrowers looking to address their rapidly approaching maturity walls. Proceeds allocated for refinancings swelled to roughly $76 billion, or over 41% of the monthly total. Pharmaceutical concern AbbVie Inc. placed the largest deal in this category: $8 billion across seven parts to be used to address various 2026 bond maturities and loans that come due this year. Biopharmaceutical peer Amgen Inc. ended a three-year hiatus to place a $4 billion, four-part offering to repay dollar and sterling 2026 bonds, along with a term loan due later this year.

While secondary spreads were wider in February, average new-issue spreads remained close to January levels. Single-A paper cleared on average at T+72 last month, just one basis point wider than the quarterly average so far. Similarly, triple-B notes printed at T+109 in February, a few basis points tighter than in January.

Meanwhile, clearing yields held steady. The average new-issue yield ticked up to 4.90% in February from 4.82% in the prior month. That marks a sixth straight month with averages below 5% (including a low at 4.73% in October), down from 5.53% in January 2025, and 5.32% last February.

Play it safe
While the Iran conflict presents a new cadre of risk scenarios, investors were already finding good shelter in defensive positions through February’s intense crosswinds (tariffs, AI, Fed policy, etc.). The 10-year Treasury rate dropped from roughly 4.25% at the start of February to a YTD low of 3.96% on Feb. 27.

That drove a 2.77% gain for the 10-year Treasury, more than doubling the gain for IG corporates (up 1.3%) and topping a thin 0.18% return for HY. Treasuries are also outperforming YTD, and their 1.52% gain for the last three months similarly leads over IG (up 1.28%) and HY (up 1.33%).

The risk-off pivot dealt the S&P 500 Index a 0.76% loss for February, after a tentative 1.45% gain in January. The trailing gains remain impressive (the index is up about 17% for the last 12 months), but net gains have flattened to less than 1% over the last three months.

Featured image by SOPA Images/SOPA Images/LightRocket via Getty Images

Learn about our editorial standards.